Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SCP-776 by Silver Creek Pharmaceuticals for Myocardial Infarction: Likelihood of Approval
SCP-776 is under clinical development by Silver Creek Pharmaceuticals and currently in Phase I for Myocardial Infarction. According to GlobalData,...